OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 01, 2011
A Silver Lining
Ilogistica has built a brand new warehouse facility with the latest technology to keep up with outsourcing demands
Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help
This loosely populated nation of almost 17 million is considered to be Latin America's economic powerhouse, with a pharmaceutical industry estimated at $1.5 billion
The parnership between academia and industry is evolving. Will it keep innovation at a premium?
These days, learning to strategically do more with less can keep your sales force performing at a high level
Dutch-based DSM N.V. is seeking innovatinve ways to partner through bolstering manufacturing
William Looney, Editor-in-Chief, last month took home the award for "Best Commentary"
Pfizer's Sarah Krug describes what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century
Espacio Riesco has adapted to the needs of pharma companies with the largest event space in Chile
GSK's Deirdre Connelly puts the focus on four steps to cement a new compliance culture
It can take both a clinical and non-clinical approach to win the differentiation competition
The determination of Pfizer's Freda Lewis-Hall has enabled her to find a ray of hope in every situation she's encountered
A true performance culture has to focus on the mundane as much as the sublime
EU leadership on pharma policy leaves many wondering of the right man is at the helm
Courts, Congress review policies and programs shaping drug costs and access